ArticleProceedings of the National Academy of Sciences of the United States of America2012

Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.

Ga Young Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.